GE HealthCare Appoints AT&T CFO Pascal Desroches to Board of Directors
GE HealthCare Technologies Inc.
Subscribe to track GEHC
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
GE HealthCare Technologies Inc. (NASDAQ: GEHC) - Form 8-K Analysis
Event: Appointment of Director Director Appointed: Pascal Desroches Effective Date: January 4, 2027 Committees Assigned: Audit Committee; Talent, Culture, and Compensation Committee
Summary: GE HealthCare announced the appointment of Pascal Desroches, current Senior Executive VP and CFO of AT&T, to its Board of Directors effective January 4, 2027. Mr. Desroches will also serve on the Audit Committee and Talent, Culture, and Compensation Committee. He will receive standard non-employee director compensation.
Comprehensive Analysis
Executive Summary
On September 22, 2026, GE HealthCare Technologies Inc. (NASDAQ: GEHC) filed a Current Report on Form 8-K under Items 5.02, 7.01, and 9.01 reporting the election of Pascal Desroches to its Board of Directors, effective January 4, 2027.
Key Appointment Details
- Appointee: Pascal Desroches
- Role: Non-Employee Director
- Effective Date: January 4, 2027
- Committee Appointments:
- Member, Audit Committee
- Member, Talent, Culture, and Compensation Committee
- Background: Mr. Desroches is currently the Senior Executive Vice President and Chief Financial Officer of AT&T Inc. (retiring December 31, 2026). Prior roles include CFO of WarnerMedia and CFO of Turner Broadcasting, with early-career experience at KPMG and the SEC. He also sits on the boards of Honeywell Aerospace and the Federal Reserve Bank of Dallas, and previously served on the board of DaVita.
Compensation & Governance Terms
- Director Compensation: Mr. Desroches will receive compensation under GE HealthCare's non-employee director compensation program as described in its Definitive Proxy Statement filed on March 19, 2026.
- Indemnification: The company will enter into its standard form indemnification agreement with Mr. Desroches.
- Related-Party Disclosures: There are no reportable transactions under Item 404(a) of Regulation S-K and no arrangements between Mr. Desroches and other persons pursuant to which he was selected.
Trading Significance
- Assessment: Low
- Rationale: This is a routine governance update regarding a future-dated board appointment with standard non-employee director compensation and no direct equity market transaction.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
